• <div id="y09gn"></div>
  • <li id="y09gn"></li>
    <dl id="y09gn"></dl>
    <div id="y09gn"><s id="y09gn"></s></div>
    来宝网Logo

    热门词:生物显微镜 水质分析仪 微波消解 荧光定量PCR 电化学工作站 生物安全柜

    现在位置首页>技术资料首页>行业动态>公司动态>珀金埃尔默仪器收购美国Analytica of Branford, Inc.(质谱离子源技术先驱企业)

    珀金埃尔默仪器收购美国Analytica of Branford, Inc.(质谱离子源技术先驱企业)

    PerkinElmer2009年6月3日 19:19 点击:1804

    Download PDF
    马萨诸塞沃尔瑟姆,2009 年 5 月 5 日(商业资讯)-- 专注于提高人类及环境健康和安全的全球领先者 PerkinElmer 公司 (NYSE: PKI) 收购了 Analytica of Branford 公司,该公司是一家公认的质谱 (MS) 技术和离子源技术的先驱和领先企业。这次收购是 PerkinElmer 继续加?#31185;?#20154;类和环境健康系列产品的战略?#20449;?#24517;不可少的环节。收购条款并未公开。

    完成这次收购后,PerkinElmer 对质谱仪和离子源技术领域的了解将大大增加,并将获得该领域的知识产权。

    “质谱仪已证明是许多领域的必备工具,并将继续发挥其重要作用。引入 Analytica 技术并吸纳具有高度创新精神的专家将会显著提高我们在这一领域的能力,”PerkinElmer 分析科学部总裁 Richard Begley 博士说。“通过对 Analytica 的收购,我?#24378;?#20197;向客户提供诸如飞行时间和四极杆质谱仪以及新型离子源之类的关键技术,从而提供更完整的信息和更高的通量。”

    Analytica 的先进技术是对 PerkinElmer 人类和环境健康系列产品的有益补充。在人类健康应用方面,质谱仪可以在新药研发和分子级诊断中提供有关医疗材料极为详尽的信息。该技术同时也是环境检测和分析以及工业监控的基础。应用领域包括环境分析、药品和保健品材料分析、法医学和食品安全。

    “这是一个千载难逢的机遇,可以将我们卓越的应用和解决方案应用于 PerkinElmer 更新、更广泛的终端市场,”Analytica 的?#35789;?#20154;兼前总裁 Craig Whitehouse 说。“我们期待通过整合我们的资源来开发和提供对人类和环境都至关重要的应用。”

    PerkinElmer 会将 Analytica 当前的生产操作整合到其位于康涅狄格州舍尔顿的公司中,而将 Analytica 现有的位于布兰福德市的公司用于研发项目。Craig Whitehouse 将成为 PerkinElmer 的员工,负责监管 PerkinElmer 的质谱仪研发运营。

    Analytica 是一家质谱技术的先驱企业,引领着质谱领域新技术?#22982;?#23637;方向。Analytica 位于康涅狄格州布兰福德市,于 1987 由 Craig Whitehouse 创立,Craig Whitehouse 开发了质谱仪首批电喷雾离子源之一。从此与质谱仪相连接的电喷雾离子源即成为分析应用中广泛使用的工具。自 1989 年以来,Analytica 一直致力于向现有质谱仪推广其离子源技术,同时它还是其它分析仪器公司的供应商。

    关于 PerkinElmer, Inc.

    PerkinElmer, Inc. 是一家专注于提高人类及环境的健康和安全的全球领先公司。据报道,该公司 2008 年收入约为 20 亿美元,拥有约 8,500 名员工,为超过 150 个国家/地区的客户提供服务,同时该公司也是标准普尔 500 指数的成员。有关其它信息,请访问 www.perkinelmer.com 或致电 1-877-PKI-NYSE。

    影响未来业绩的因素

    此新闻稿包含的前瞻性声明依据 1995 年“美国私人证券诉讼修正法案”(United States Private Securities Litigation Reform Act of 1995) 中的有关规定发布,其中包括但不限于与未来每股股票收益、现金流和收入增长及其它财务结果的预测和?#20848;?#26377;关的声明、与我们的客户和最终市场有关?#22982;?#23637;以及与企业发展机会相关的计划。“相信”、“意图”、“期待”、“计划”、“期望”、“预计”、“预想”、“将会”等词汇及其相似表达均可作为判定前瞻性声明的依据。此类声明是基于管理层的当前设想和预期做出的,我们无法保证所有的设想或预期都完全正确。许多重要?#22982;?#38505;因素可能会导致实?#24335;?#26524;与任何前瞻性声明中所描述的、暗示的或预计的结果存在显著差异。这些因素包括但不限于:(1) 我们的产品销售市场萎缩或者未达到预期发展水平;(2) 全球性的经济、政治和其它风险;(3) 公司未能及时推出新产品;(4) 执行收购和获得许可技术的能力,或将已收购业务和许可技术成功整?#29616;?#20844;司现有业务或使其变得可赢利的能力;(5) 未能充分地保护公司的知识产权;(6) 公司失去任何许可或许可权;(7) 公司进行强有力竞争的能力;(8) 公司的季度运营结果出现波动以及调整公司的运营来解决意外变故的能力;(9) 第三方软件包供应和进口/出口服务出现重大中断或以上服务的价格大大增加;(10) 原材料、关键组件和供应品供应中断;(11) 制造和销售产品可能会使我们遭受产品责任索赔;(12) 未能严格遵守适用的政府法规;(13) 法规变更;(14) 未能符合保健行业?#22982;?#35268;要求;(15) 经济、政?#25105;?#21450;与外部运营相关的其它风险;(16) 与重要人员保持雇佣关系的能力;(17) 公司信息技术系统的重大中断或未能成功实施新系统;(18) 公司信用协议中的限制;(19) 认识到无形资产的完全价值的能力;(20) 股票价格的显著变化;(21) 未来的股票红利可能减少或停止派发以及 (22) 其它因素,这些因素在最新的 10-K 年度报表的“风险因素”(Risk Factors) 标题下以及我们向美国证券交易委员会提供的其它档案中进行了?#24471;鰲?#22312;此新闻稿发出后,本公司?#29260;?#23601;发生的进展更新任何前瞻性声明的意图和义务。

    来源:PerkinElmer, Inc.

    投?#25910;?#20851;系:
    PerkinElmer, Inc.
    Dave C. Francisco, 781-663-5677

    媒体联系人:
    PerkinElmer, Inc.
    Stephanie R. Wasco 781-663-5701
    [email protected]

    其他媒体联系人:
    PerkinElmer 分析科学部
    Chris P. Tessier, 203-402-6872
    [email protected]

    WALTHAM, Mass., May 05, 2009 (BUSINESS WIRE) -- PerkinElmer, Inc. (NYSE: PKI), a global leader focused on improving the health and safety of people and the environment, has acquired Analytica of Branford, Inc., a recognized pioneer and leader in mass spectrometry (MS) and ion source technology. The acquisition is an integral part of PerkinElmer's strategic commitment to continue to grow its human and environmental health portfolio. Terms of the acquisition were not disclosed.

    With the completion of this acquisition, PerkinElmer will gain significant insight and intellectual property in the field of MS and ion source technology.

    "Mass spectrometry has proven to be an essential tool in many fields and will continue to be of critical importance. Bringing Analytica's technology and team of highly innovative experts in-house will dramatically increase our capabilities in this area," said Richard Begley, Ph.D., president, Analytical Sciences, PerkinElmer. "The acquisition of Analytica will allow us to offer our customers access to critical technologies such as time-of-flight and quadrupole mass spectrometers and new ion sources that provide more complete information as well as better throughput."

    Analytica's advanced technology complements PerkinElmer's human and environmental health portfolio. For human health applications, mass spectrometry provides an extremely detailed profile of medically relevant materials in drug discovery and molecular diagnostics. This technology is also the cornerstone of environmental detection and analysis and industrial monitoring. Areas of applications include environmental analysis, pharmaceutical and nutraceutical materials analysis, forensics and food safety.

    "This is a wonderful opportunity to apply our outstanding applications and solutions to PerkinElmer's new and broader end markets," said Craig Whitehouse, founder and former president of Analytica. "We look forward to combining our resources to develop and provide applications that are critical to people and the environment."

    PerkinElmer will integrate Analytica's current manufacturing operations into its Shelton, CT facility, while utilizing Analytica's existing Branford facility for R&D projects. Craig Whitehouse will become an employee of PerkinElmer and oversee PerkinElmer's MS R&D operations.

    Analytica is a pioneer, leading the way with new advances in the field of mass spectrometry. Located in Branford, Connecticut, Analytica was founded in 1987 by Craig Whitehouse, who developed one of the first electrospray ion sources for MS. Electrospray ionization sources interfaced to mass spectrometers have since become widely used tools in analytical applications. Since 1989, Analytica has been marketing its technology for existing mass spectrometers and acting as a supplier to other analytical instrument companies.

    About PerkinElmer, Inc.

    PerkinElmer, Inc. is a global leader focused on improving the health and safety of people and the environment. The Company reported revenue of approximately $2 billion in 2008, has around 8,500 employees serving customers in more than 150 countries, and is a component of the S&P 500 Index. Additional information is available through www.perkinelmer.com or 1-877-PKI-NYSE.

    Factors Affecting Future Performance

    This press release contains "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements relating to estimates and projections of future earnings per share, cash flow and revenue growth and other financial results, developments relating to our customers and end-markets, and plans concerning business development opportunities. Words such as "believes," "intends," "anticipates," "plans," "expects," "projects," "forecasts," "will" and similar expressions, and references to guidance, are intended to identify forward-looking statements. Such statements are based on management's current assumptions and expectations and no assurances can be given that our assumptions or expectations will prove to be correct. A number of important risk factors could cause actual results to differ materially from the results described, implied or projected in any forward-looking statements. These factors include, without limitation: (1) markets into which we sell our products decline or do not grow as anticipated; (2) global economic, political and other risks; (3) our failure to introduce new products in a timely manner; (4) our ability to execute acquisitions and license technologies, or to successfully integrate acquired businesses and licensed technologies into our existing business or to make them profitable; (5) our failure to adequately protect our intellectual property; (6) the loss of any of our licenses or licensed rights; (7) our ability to compete effectively; (8) fluctuation in our quarterly operating results and our ability to adjust our operations to address unexpected changes; (9) significant disruption in third-party package delivery and import/export services or significant increases in prices for those services; (10) disruptions in the supply of raw materials, key components and supplies; (11) the manufacture and sale of products may expose us to product liability claims; (12) our failure to maintain compliance with applicable government regulations; (13) regulatory changes; (14) our failure to comply with health care industry regulations; (15) economic, political and other risks associated with foreign operations; (16) our ability to retain key personnel; (17) significant disruption in our information technology systems or the failure to successfully implement new systems; (18) restrictions in our credit agreements; (19) our ability to realize the full value of our intangible assets; (20) significant fluctuations in our stock price; (21) dividends we pay on our stock could be reduced or eliminated in the future; and (22) other factors which we describe under the caption "Risk Factors" in our most recent annual report on Form 10-K and in our other filings with the Securities and Exchange Commission. We disclaim any intention or obligation to update any forward-looking statements as a result of developments occurring after the date of this press release.

     

    SOURCE: PerkinElmer, Inc.

    Investor Relations:
    PerkinElmer, Inc.
    Dave C. Francisco, 781-663-5677
    or
    Media Contact:
    PerkinElmer, Inc.
    Stephanie R. Wasco, 781-663-5701
    [email protected]
    or
    Additional Media Contact:
    PerkinElmer Analytical Sciences
    Chris P. Tessier, 203-402-6872
    [email protected]

    Copyright Business Wire 2009

    关于 珀金埃尔默仪器
    关于 Analytica of Branford, Inc.

    (来源: PerkinElmer )


    全年征稿 / 资讯合作

    联系邮箱:[email protected]

    版权与免责声明

    • 凡本网注明“来源:来宝网”的所有作品,版权均属于来宝网,转载请必须注明来宝网, http://www.67994619.com,违反者本网将追究相关法律责任。
    • 本网转载并注明自其它来源的作品,?#24247;?#22312;于传递更多信息,并不代表本网赞同其观点或证实其内容的真实性,不承担此类作品侵权行为的直接责任及连带责任。其他媒体、网站或个人从本网转载时,必须保留本网注明的作品来源,并自负版权等法律责任。
    • 如涉及作品内容、版权等问题,请在作品发表之日起一周内与本网联系,否则视为?#29260;?#30456;关权利。


    云南11选5技巧
  • <div id="y09gn"></div>
  • <li id="y09gn"></li>
    <dl id="y09gn"></dl>
    <div id="y09gn"><s id="y09gn"></s></div>
  • <div id="y09gn"></div>
  • <li id="y09gn"></li>
    <dl id="y09gn"></dl>
    <div id="y09gn"><s id="y09gn"></s></div>
    六肖中特准免费神算子 p3试机号近200期 七位数历史开奖走势图 秒速飞艇稳赢 投注站有足彩半全场吗 广西快乐十分官网app 老快3遗漏号360 内蒙赛马会 期期好彩一尾中特 安徽快三走势图一定牛 体彩总进球数规则 php彩票网站 辽宁11选5加奖 山西快乐10分中奖规则 2017年3d选号规律